Matthew M Schaefers, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Burkholderia | 3 | 2021 | 36 | 1.610 |
Why?
|
Burkholderia Infections | 3 | 2021 | 41 | 1.430 |
Why?
|
Pseudomonas Infections | 5 | 2024 | 622 | 1.030 |
Why?
|
Burkholderia cepacia complex | 3 | 2021 | 24 | 0.930 |
Why?
|
Pseudomonas Vaccines | 3 | 2022 | 24 | 0.840 |
Why?
|
Bacterial Physiological Phenomena | 1 | 2020 | 119 | 0.670 |
Why?
|
Superantigens | 4 | 2012 | 127 | 0.640 |
Why?
|
Bacterial Proteins | 5 | 2022 | 3842 | 0.570 |
Why?
|
Enterotoxins | 4 | 2012 | 367 | 0.570 |
Why?
|
Hemeproteins | 1 | 2017 | 61 | 0.560 |
Why?
|
Point Mutation | 1 | 2021 | 1595 | 0.520 |
Why?
|
Pneumonia | 4 | 2024 | 2140 | 0.520 |
Why?
|
Pneumonia, Bacterial | 1 | 2018 | 316 | 0.510 |
Why?
|
Drug Carriers | 1 | 2018 | 706 | 0.450 |
Why?
|
Biofilms | 3 | 2018 | 627 | 0.450 |
Why?
|
Th17 Cells | 3 | 2022 | 792 | 0.450 |
Why?
|
Bacterial Toxins | 5 | 2012 | 932 | 0.450 |
Why?
|
Antigens, Bacterial | 1 | 2018 | 1155 | 0.420 |
Why?
|
Evolution, Molecular | 1 | 2021 | 1891 | 0.420 |
Why?
|
Staphylococcus aureus | 5 | 2017 | 1459 | 0.390 |
Why?
|
Host-Pathogen Interactions | 1 | 2020 | 1454 | 0.380 |
Why?
|
Curcumin | 1 | 2012 | 98 | 0.370 |
Why?
|
Cystic Fibrosis | 4 | 2024 | 1284 | 0.370 |
Why?
|
Protective Agents | 1 | 2012 | 150 | 0.370 |
Why?
|
Flagella | 2 | 2018 | 99 | 0.280 |
Why?
|
Virulence | 2 | 2021 | 1301 | 0.280 |
Why?
|
Inflammation Mediators | 1 | 2012 | 1886 | 0.210 |
Why?
|
Gene Expression Regulation, Bacterial | 2 | 2020 | 1133 | 0.200 |
Why?
|
Pseudomonas aeruginosa | 5 | 2024 | 1278 | 0.200 |
Why?
|
Epithelial Cells | 3 | 2012 | 3661 | 0.190 |
Why?
|
Laurates | 2 | 2009 | 7 | 0.170 |
Why?
|
Monoglycerides | 2 | 2009 | 10 | 0.170 |
Why?
|
Flagellin | 2 | 2017 | 124 | 0.170 |
Why?
|
Interleukin-8 | 3 | 2012 | 696 | 0.160 |
Why?
|
Virulence Factors | 2 | 2020 | 512 | 0.150 |
Why?
|
Vaccines, Subunit | 1 | 2018 | 161 | 0.150 |
Why?
|
Bacterial Load | 1 | 2018 | 151 | 0.150 |
Why?
|
Peritoneal Cavity | 1 | 2017 | 135 | 0.140 |
Why?
|
Anaerobiosis | 1 | 2017 | 138 | 0.140 |
Why?
|
Isoflurane | 2 | 2017 | 384 | 0.140 |
Why?
|
Administration, Intranasal | 1 | 2018 | 477 | 0.140 |
Why?
|
Lac Operon | 1 | 2017 | 237 | 0.140 |
Why?
|
Vagina | 3 | 2012 | 838 | 0.140 |
Why?
|
Swimming | 1 | 2018 | 208 | 0.140 |
Why?
|
Macrophage-1 Antigen | 1 | 2017 | 286 | 0.130 |
Why?
|
Lung | 3 | 2021 | 9973 | 0.130 |
Why?
|
Vaccines, Synthetic | 1 | 2018 | 619 | 0.130 |
Why?
|
Lymphocyte Function-Associated Antigen-1 | 1 | 2017 | 377 | 0.130 |
Why?
|
Disease Models, Animal | 5 | 2018 | 18216 | 0.120 |
Why?
|
Respiratory Tract Infections | 1 | 2022 | 1010 | 0.110 |
Why?
|
Shock, Septic | 2 | 2012 | 764 | 0.110 |
Why?
|
Bacterial Infections | 1 | 2022 | 1406 | 0.110 |
Why?
|
Rabbits | 4 | 2012 | 4780 | 0.110 |
Why?
|
Interleukin-17 | 1 | 2018 | 907 | 0.100 |
Why?
|
Mice, Inbred C57BL | 3 | 2021 | 22121 | 0.100 |
Why?
|
Anesthetics, Inhalation | 1 | 2017 | 574 | 0.100 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 3800 | 0.090 |
Why?
|
Anesthetics | 1 | 2017 | 523 | 0.090 |
Why?
|
Animals | 12 | 2024 | 168253 | 0.090 |
Why?
|
Enzyme Activation | 1 | 2017 | 3592 | 0.090 |
Why?
|
Cell Line, Transformed | 1 | 2012 | 868 | 0.090 |
Why?
|
Sepsis | 2 | 2017 | 2583 | 0.090 |
Why?
|
Sus scrofa | 1 | 2012 | 428 | 0.090 |
Why?
|
Survival Analysis | 3 | 2018 | 10075 | 0.090 |
Why?
|
Cariostatic Agents | 1 | 2009 | 31 | 0.090 |
Why?
|
Menstrual Hygiene Products | 1 | 2009 | 20 | 0.090 |
Why?
|
Mucous Membrane | 1 | 2012 | 657 | 0.080 |
Why?
|
Flow Cytometry | 1 | 2018 | 5865 | 0.070 |
Why?
|
Chemokines | 1 | 2012 | 960 | 0.070 |
Why?
|
Endocarditis | 1 | 2012 | 350 | 0.070 |
Why?
|
Mice | 5 | 2024 | 81402 | 0.070 |
Why?
|
Lipase | 1 | 2009 | 324 | 0.070 |
Why?
|
Disease Outbreaks | 1 | 2017 | 1762 | 0.070 |
Why?
|
Macrophages | 1 | 2021 | 5764 | 0.070 |
Why?
|
Cell Line | 2 | 2018 | 15598 | 0.070 |
Why?
|
Cytokines | 2 | 2018 | 7377 | 0.060 |
Why?
|
Bacteria | 1 | 2017 | 2217 | 0.060 |
Why?
|
Staphylococcal Infections | 2 | 2012 | 1409 | 0.060 |
Why?
|
Promoter Regions, Genetic | 1 | 2017 | 5778 | 0.060 |
Why?
|
Oxygen | 1 | 2017 | 4222 | 0.060 |
Why?
|
Antibodies, Bacterial | 2 | 2022 | 1469 | 0.060 |
Why?
|
Signal Transduction | 2 | 2020 | 23397 | 0.050 |
Why?
|
Phenotype | 1 | 2021 | 16585 | 0.050 |
Why?
|
NF-kappa B | 1 | 2012 | 2485 | 0.050 |
Why?
|
Amino Acids | 1 | 2008 | 1717 | 0.050 |
Why?
|
Immune Sera | 1 | 2022 | 613 | 0.050 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2024 | 449 | 0.050 |
Why?
|
Female | 7 | 2021 | 391875 | 0.040 |
Why?
|
Drug Resistance, Microbial | 1 | 2022 | 857 | 0.040 |
Why?
|
Humans | 10 | 2024 | 760437 | 0.040 |
Why?
|
Antibody Formation | 1 | 2022 | 1397 | 0.040 |
Why?
|
Enterococcus faecalis | 1 | 2017 | 246 | 0.030 |
Why?
|
Methyl Ethers | 1 | 2017 | 196 | 0.030 |
Why?
|
Neutrophil Infiltration | 1 | 2017 | 387 | 0.030 |
Why?
|
Binding Sites | 2 | 2017 | 6042 | 0.030 |
Why?
|
Drug Resistance, Bacterial | 1 | 2022 | 1058 | 0.030 |
Why?
|
Genes, Bacterial | 1 | 2018 | 1079 | 0.030 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2018 | 2749 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2018 | 1337 | 0.030 |
Why?
|
Retrospective Studies | 1 | 2021 | 80430 | 0.030 |
Why?
|
Lethal Dose 50 | 1 | 2012 | 72 | 0.030 |
Why?
|
Colony Count, Microbial | 1 | 2012 | 330 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2024 | 9533 | 0.020 |
Why?
|
Phagocytosis | 1 | 2017 | 1536 | 0.020 |
Why?
|
Propofol | 1 | 2017 | 603 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2022 | 4549 | 0.020 |
Why?
|
Escherichia coli Proteins | 1 | 2017 | 1067 | 0.020 |
Why?
|
Exotoxins | 1 | 2009 | 121 | 0.020 |
Why?
|
Staphylococcus | 1 | 2009 | 156 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2018 | 6086 | 0.020 |
Why?
|
Culture Techniques | 1 | 2008 | 531 | 0.020 |
Why?
|
Cell Membrane Permeability | 1 | 2008 | 575 | 0.020 |
Why?
|
Injections, Intravenous | 1 | 2008 | 1379 | 0.020 |
Why?
|
Alanine | 1 | 2008 | 606 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2018 | 13445 | 0.020 |
Why?
|
Escherichia coli | 1 | 2017 | 4234 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2022 | 7424 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2018 | 7996 | 0.010 |
Why?
|
Mutation | 2 | 2022 | 30025 | 0.010 |
Why?
|
Anti-Infective Agents | 1 | 2009 | 984 | 0.010 |
Why?
|
Fatty Acids | 1 | 2009 | 1805 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2017 | 14397 | 0.010 |
Why?
|
Swine | 1 | 2008 | 5915 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2009 | 4355 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2008 | 5491 | 0.010 |
Why?
|
Base Sequence | 1 | 2008 | 12449 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2009 | 10759 | 0.010 |
Why?
|
Genotype | 1 | 2012 | 12976 | 0.010 |
Why?
|
Peptides | 1 | 2008 | 4338 | 0.010 |
Why?
|
Time Factors | 1 | 2017 | 39947 | 0.010 |
Why?
|
Young Adult | 1 | 2009 | 59068 | 0.000 |
Why?
|
Adolescent | 1 | 2009 | 88196 | 0.000 |
Why?
|
Adult | 1 | 2009 | 220781 | 0.000 |
Why?
|
Male | 1 | 2009 | 360035 | 0.000 |
Why?
|